Heron Therapeutics is trading at $0.32, up +5.99%, with no confirmed company-specific catalyst identified for October 27. - The company announced its third-quarter results call for November 9; the upcoming event does not establish a reason for today’s move. - Biotech shares are broadly higher, with XBI up 2.18%; sector strength may be supportive but does not confirm the cause of Heron Therapeutics’ larger gain. - Trading volume and activity data were not available.